Etanercept given every week subcutaneously Adalimumab given every 2 weeks subcutaneously Infliximab given every 6 to 8 weeks intravenously Certolizumab pegol given every 2 to 4 weeks subcutaneously Golimumab given monthly subcutaneously Simponi ARIA given every 8 weeks intravenously There are other, less common biologic agents that can interrupt the inflammatory process, including: Tocilizumab (Actemra) Sarilumab (Kevzara) Abatacept (Orencia) These too, are given either subcutaneously or through IV every few weeks
Most sleep research points to 18 to 20 degrees Celsius as the optimal range for sleeping
Estrogen dominance a condition in which estrogen levels are disproportionately high relative to progesteronehas been linked to: Fibroids Thyroid nodules Endometriosis Heavy menstrual cycles Dense breast tissue and breast cysts Increased breast cancer risk Women with estrogen dominance often have larger breasts and hips and may struggle with weight gain
Adults in Florida may ask about peptide therapy when they want personalized support for recovery, wellness, energy, metabolism, body composition, sleep, skin quality, or healthy aging